Rhythm versus rate control trials in atrial fibrillation

Journal of Cardiovascular Electrophysiology

Volumn 14, Issue 9 SUPPL., 2003, Pages

  Wyse, D George ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Atrial fibrillation; Heart rate control strategy; Randomized clinical trial; Rhythm control strategy

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DILTIAZEM; FLECAINIDE; PROPAFENONE; SOTALOL; VERAPAMIL; WARFARIN;

ANTICOAGULANT THERAPY; BLEEDING; BRAIN HEMORRHAGE; CARDIOVERSION; CAUSE OF DEATH; CLINICAL TRIAL; COMPARATIVE STUDY; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; DRUG SAFETY; EMBOLISM; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART RATE; HUMAN; LONG TERM CARE; META ANALYSIS; MORTALITY; PATIENT SELECTION; PRIORITY JOURNAL; SINUS RHYTHM; STROKE; THROMBOSIS; TREATMENT FAILURE;

EID: 0141613051     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.14.s9.17.x     Document Type: Conference Paper

References (12)

1. Wyse DG: Selection of endpoints in atrial fibrillation studies. J Cardiovasc Electrophysiol 2002;13(Suppl):S47-S52.
2. Miller MR, McNamara RL, Segal JB, Kim N, Robinson KA, Goodman SN, Powe NR, Bass EP: Efficacy of agents for pharmacological conversion of atrial fibrillation and subsequent maintenance of sinus rhythm: A meta analysis of clinical trials. J Fam Pract 2000;49:1033-1046.
3. Flaker GC, Blackshear JL, McBride R, Kronmal RA, Halperin JL, Hart RG: Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. J Am Coll Cardiol 1992;20:527-532.
4. Connolly SC: Preventing stroke in patients with atrial fibrillation: Current treatments and new concepts. Am Heart J 2003;145:430-437.
5. Hohnloser SH, Kuck K-H, Lilienthal J, for the PIAF Investigators: Rhythm or rate control in atrial fibrillation-Pharmacologic Intervention in Atrial Fibrillation (PIAF): A randomized trial. Lancet 2000;356:1789-1794.
6. Brignole M, Menozzi C, Gasparini M, Bongiorni MG, Botto GL, Ometto R, Alboni P, Bruna C, Vincenti A, Verlato R, for the PAF 2 Investigators: An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation. Eur Heart J 2002;23:892-900.
7. The AFFIRM Investigators: A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-1833.
8. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns HJ, for the RACE Investigators: A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002;347:1834-1840.
9. Carlsson J, Miketic S, Windeler J, Cuneo A, Haun S, Micus S, Walter S, Tebbe U, for the STAF Investigators: Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: STAF Trial. J Am Coll Cardiol 2003; (in press).
10. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE: Prevalence of diagnosed atrial fibrillation in adults. National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370-2375.
11. Vora AM, Goyal VS, Naik AM, Lokhandwala YY, Gupta A, Karnad DR, Kulkarni HL, Singh B: Maintenance of sinus rhythm by amiodarone is superior to ventricular rate control in rheumatic atrial fibrillation: A blinded placebo-controlled study. Pacing Clin Electrophysiol (Abstract) 2001;24:546.
12. The AF-CHF Investigators: Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: The Atrial Fibrillation and Congestive Heart Failure (AF-CHF) Trial. Am Heart J 2002;144:597-607.